Joshua Atchley v. AstraZeneca UK Limited

CourtCourt of Appeals for the D.C. Circuit
DecidedJanuary 23, 2026
Docket20-7077
StatusPublished

This text of Joshua Atchley v. AstraZeneca UK Limited (Joshua Atchley v. AstraZeneca UK Limited) is published on Counsel Stack Legal Research, covering Court of Appeals for the D.C. Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Joshua Atchley v. AstraZeneca UK Limited, (D.C. Cir. 2026).

Opinion

United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT

Argued November 19, 2024 Decided January 23, 2026

No. 20-7077

JOSHUA ATCHLEY, ET AL., APPELLANTS

v.

ASTRAZENECA UK LIMITED, ET AL., APPELLEES

On Remand from the Supreme Court of the United States

Joshua D. Branson argued the cause for appellants. With him on the supplemental briefs were David C. Frederick, Andrew E. Goldsmith, and Derek C. Reinbold.

Stephen I. Vladeck was on the supplemental brief for amici curiae Law Professors in support of appellants.

Lisa S. Blatt argued the cause for appellees. With her on the supplemental briefs were Kannon K. Shanmugam, Jeh C. Johnson, William T. Marks, Christopher N. Manning, Sarah M. Harris, Melissa B. Collins, Aaron Z. Roper, Jessica S. Carey, John B. Bellinger III, David J. Weiner, Robert Reeves Anderson, David M. Zionts, David W. Bowker, Catherine M.A. 2 Carroll, Donna M. Farag, Paul S. Mishkin, and David B. Toscano. Alex Young K. Oh entered an appearance.

Jordan L. Von Bokern, Andrew J. Pincus, and Robert W. Hamburg were on the brief for amicus curiae The Chamber of Commerce of the United States of America in support of appellees.

Timothy P. Harkness, Kimberly H. Zelnick, Scott A. Eisman, Adam Rosenfeld, Maria Slobodchikova, and Elischke De Villiers were on the brief for amicus curiae Charity & Security in support of appellees.

Before: PILLARD and WILKINS, Circuit Judges, and EDWARDS, Senior Circuit Judge.

Opinion for the Court filed by Circuit Judge PILLARD.

PILLARD, Circuit Judge: The terrorist group Jaysh al- Mahdi injured or killed hundreds of United States service members and civilians as part of its years-long campaign to harm Americans and drive the United States military out of Iraq. Plaintiffs are victims of Jaysh al-Mahdi’s attacks and family members of victims. During the period in which the victims were attacked, Jaysh al-Mahdi openly controlled Iraq’s Ministry of Health (Ministry) and used it as a vehicle to direct terrorist activity against Americans. Plaintiffs claim defendants, large pharmaceutical and medical equipment manufacturers and suppliers, knowingly gave substantial assistance to the attacks that injured them, violating the Anti- Terrorism Act (ATA), as amended by the Justice Against Sponsors of Terrorism Act, and state law.

Plaintiffs allege that defendants assisted Jaysh al-Mahdi by doing business with the Ministry in an unusual and unlawful 3 way, to the benefit of the terrorist group. According to the complaint, defendants paid illegal cash bribes directly to the group and supplied extra, off-the-books batches of valuable medical goods that Jaysh al-Mahdi monetized on the black market to fund its operations against Americans. As they did so, defendants knew that the funds and goods they were gratuitously providing to Jaysh al-Mahdi financed its attacks against Americans, including the victims in this case. Defendants’ agents finalized contracts at in-person meetings at the Ministry, where conspicuous displays of Jaysh al-Mahdi weaponry, fighters, and propaganda made clear who was in charge. And defendants’ compliance personnel had access to contemporaneous reports in mainstream media that detailed the terrorists’ control of the Ministry and their use of cash and in- kind bribes to fund attacks. Over the period in question, plaintiffs allege defendants repeatedly and voluntarily renewed contracts with and provided illegal bribes to Jaysh al-Mahdi, with payments occurring on the heels of attacks against Americans and providing support for further attacks.

The district court held that the complaint failed to state claims for either primary (direct) or secondary (aiding-and- abetting) liability under the ATA and that the court lacked personal jurisdiction over six foreign defendants. On appeal, we reversed, holding that plaintiffs had pleaded facts sufficient to support their aiding-and-abetting claims, that plaintiffs had adequately pleaded that defendants’ payments to Jaysh al- Mahdi proximately caused plaintiffs’ injuries on the direct liability claims, and that U.S. federal courts had personal jurisdiction over the foreign defendants. Shortly afterward, the Supreme Court granted defendants’ petition for a writ of certiorari, vacated our decision, and remanded the case to us for further consideration in light of Twitter, Inc. v. Taamneh, 598 U.S. 471 (2023), which clarified the scope of secondary liability under the ATA. 4 Having considered Taamneh and with the aid of supplemental briefing and oral argument, we reverse the district court’s dismissal of plaintiffs’ secondary liability claims. Secondary liability under the ATA, as interpreted by Taamneh, requires conscious, voluntary, and culpable participation in another’s tortious activity to ensure liability is limited to conduct that is genuinely blameworthy. It also requires a nexus between defendants’ assistance and the acts of international terrorism that injure plaintiffs. Liability does not attach to those who, like the Taamneh defendants, passively and tangentially aid terrorists in the ordinary course of their business. This complaint, however, describes conduct that is far from “business as usual”—with allegations sufficient to satisfy both of Taamneh’s requirements. Plaintiffs adequately allege that defendants’ participation was conscious, voluntary, and culpable: Defendants knew their assistance would be used to launch attacks on plaintiffs, and they repeatedly structured their transactions in an unusual and unlawful manner that served to facilitate Jaysh al-Mahdi’s operations. Plaintiffs clearly identify a nexus between the alleged attacks and defendants’ direct cash and in-kind payments to Jaysh al- Mahdi. The attacks, which were a discrete subset of Jaysh al- Mahdi’s terrorist activities, were a natural and virtually inevitable consequence of defendants’ unusual, corrupt, and plentiful assistance.

Taamneh did not address the standard for direct liability under the ATA and so we reinstate our holding on the direct liability claims that plaintiffs adequately pleaded that defendants’ payments to Jaysh al-Mahdi proximately caused plaintiffs’ injuries. Defendants did not challenge (nor did Taamneh address) our holdings that the manufacturer defendants were not too remote from the conduct alleged to be held liable and that certain foreign defendants were subject to the personal jurisdiction of U.S. federal courts. Accordingly, 5 we do not disturb those holdings and remand to the district court for further proceedings consistent with our opinions.

I.

The factual and procedural background of this case is spelled out in prior opinions. See Atchley v. AstraZeneca UK Ltd., 474 F. Supp. 3d 194 (D.D.C. 2020); Atchley v. AstraZeneca UK Ltd., 22 F.4th 204 (D.C. Cir. 2022). We assume familiarity with those opinions and recapitulate the facts and procedural history most relevant following the Supreme Court’s remand. The facts are drawn from plaintiffs’ complaint and are assumed true for the purposes of reviewing defendants’ motion to dismiss. See Schubarth v. Fed. Republic of Germany, 891 F.3d 392, 395 (D.C. Cir. 2018).

In 2003, the United States invaded Iraq. Even before the invasion, Hezbollah—a Lebanese group designated as a Foreign Terrorist Organization under U.S. law since 1997— made plans to undermine the expected U.S. presence. From April 2003, Hezbollah’s “chief terrorist mastermind, Imad Mugniyeh,” collaborated with the powerful Shiite cleric Muqtada al-Sadr to establish a fighting force in Iraq to violently expel the Americans. Third Am.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Direct Sales Co. v. United States
319 U.S. 703 (Supreme Court, 1943)
Halberstam v. Welch
705 F.2d 472 (D.C. Circuit, 1983)
Rothstein v. UBS AG
708 F.3d 82 (Second Circuit, 2013)
United States v. Peoni
100 F.2d 401 (Second Circuit, 1938)
The Passaic Daily News v. Blair
308 A.2d 649 (Supreme Court of New Jersey, 1973)
Rice v. Paladin Enterprises, Inc.
128 F.3d 233 (Fourth Circuit, 1997)
Rivka Livnat v. Palestinian Authority
851 F.3d 45 (D.C. Circuit, 2017)
Mady Schubarth v. Federal Republic of Germany
891 F.3d 392 (D.C. Circuit, 2018)
James Owens v. BNP Paribas, S.A.
897 F.3d 266 (D.C. Circuit, 2018)
Joshua Atchley v. Astrazeneca UK Limited
22 F.4th 204 (D.C. Circuit, 2022)
Holder v. Humanitarian Law Project
177 L. Ed. 2d 355 (Supreme Court, 2010)
Woods v. Barnett Bank
765 F.2d 1004 (Eleventh Circuit, 1985)
Twitter, Inc. v. Taamneh
598 U.S. 471 (Supreme Court, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
Joshua Atchley v. AstraZeneca UK Limited, Counsel Stack Legal Research, https://law.counselstack.com/opinion/joshua-atchley-v-astrazeneca-uk-limited-cadc-2026.